News Results for David T. Teachey, MD

1 - 10 of 20

In the News: MIS-C, Heart Disease, Sleep Genes, Neonatal Resuscitation

Published on Jan 20, 2023 in Cornerstone Blog
In the News This week’s In the News highlights research on MIS-C, an association between serotonin and heart valve disease, a genetic basis for sleep disorders, and neonatal resuscitation guidelines.

CART38, a Novel Therapy for T-ALL: Q&A With David Teachey, MD, and Caroline Diorio, MD

Published on Jan 19, 2023 in Cornerstone Blog
Seed Grant Funds Research for CART38, a Novel Therapy for T-ALL In this Q&A, Drs. Teachey and Diorio discuss their partnership and research of a novel CAR T-cell therapy for one of the most common pediatric cancers.

In The News: MIS-C, Antibody Treatment for Eosinophilic Esophagitis, ASH 2022

Published on Jan 6, 2023 in Cornerstone Blog
Our Scientists’ Research Highlighted In the News See highlights of work by Children’s Hospital of Philadelphia researchers that is leading to novel findings.

ASH 2022: CHOP Experts Presented and Contributed to More than 200 Abstracts at National Hematology Conference

Published on Dec 20, 2022 in Press Releases
Researchers from the Division of Hematology and Division of Oncology attended the 64th Annual American Hematology Society (ASH) Meeting.

In The News: Breastfeeding, Allogeneic CART, Costa Rica Partners, CPR Education, Cognitive Outcomes

Published on May 27, 2022 in Cornerstone Blog
In the News Learn about novel findings and notable achievements from our Children’s Hospital of Philadelphia researchers.

CHOP Researchers Develop Allogeneic CART for Relapsed or Refractory T-ALL Using Base Editing

Published on May 23, 2022 in Press Releases
CHOP researchers have tested and developed an “off-the-shelf” chimeric antigen receptor T-cell (CART) using base editing.

Snapshot Science: Does Bortezomib Improve Survival in Children With T-cell Lymphoblastic Leukemia?

Published on Apr 4, 2022 in Cornerstone Blog
Does Bortezomib Improve Outcomes in T-cell Lymphoblastic Leukemia? Researchers at CHOP found that bortezomib improve survival in children with T-cell lymphoblastic lymphoma.

In The News: March of Dimes Prize, Immunotherapy, CHOP CARES, MIS-C, PCORI Grant

Published on Feb 4, 2022 in Cornerstone Blog
In the News Learn about novel findings neuroblastoma, MIS-C, and more in this week's roundup of research news.

MIS-C Patients Have Deeply Dysregulated Protein Profiles, According to New CHOP Research

Published on Jan 24, 2022 in Press Releases
The findings were published in Nature Communications.

Snapshot Science: Could Deep Immune Profile of Pediatric COVID-19 Patients Aid Understanding of Adult Disease?

Published on Mar 17, 2021 in Cornerstone Blog
Deep Immune Profiling Helps Elucidate Pathology of Severe COVID-19 Researchers used deep immune profiling to better understand immune activation in children with multisystem inflammatory syndrome.
1 - 10 of 20